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In recent years, the possible cause of schizophrenia 
has switched from an emphasis on neurotransmitter 
dysfunction to possible genetic and neurodevelop-
mental abnormalities. Th e link between the loci for 
insulin-dependent diabetes mellitus type 2,the hu-
man lymphocyte antigen system and schizophrenia 
suggests that a dysfunctional  immune system  plays a 
role in this disorder. Th is hypothesis is supported by a 
link between viral infections in utero and schizophre-
nia in the off spring; the negative correlation between 
rheumatoid arthritis and  schizophrenia  lends further 
support to this view.
Recent  studies  have  indicated  that  changes in 
the adaptive immune system  in schizophrenia result 
in an imbalance between the pro-infl ammatory and 
anti-infl ammatory  cytokines. Of the  changes  in  the 
pro-infl ammatory cytokines that have been detected 
in the blood and CSF of schizophrenic patients, inter-
leukin-6 (IL-6) has received particular attention. In 
the plasma, high concentrations of IL-6 are associated 
with both the duration of the disorder and its resist-
ance to drug treatment while the increase of IL-6 in 
the CSF is associated with the paranoid  symptoms of 
the disorder.. It is now known that IL-6 increases the 
activities of dopaminergic and serotonergic neurons 
in the hippocampus and the frontal cortex. Th ereby 
linking  the immune changes with those neurotrans-
mitters reputed to be causally connected to the psy-
chopathology of the disorder. IL-6 is suppressed by 
eff ective treatment  of the psychotic state by atypical 
antipsychotics.
Th e link between  the immune system and neuro-
degenerative changes that frequently occur  in those 
with chronic schizophrenia is provided by the in-
creased synthesis of quinolinic acid, the fi nal product 
of the tryptophan-kynurenine pathway. Th is pathway 
involves the activation of indoleamine 2,3 –dioxyge-
nase (IDO)  by IL-6 and other pro-infl ammatory cy-
tokines in many peripheral tissues and in microglia 
in the brain. In schizophrenia, there appears to be an 
imbalance between the neurodegenerative compo-
nent (quinolinic acid, a NMDA glutamate agonist) 
and the neuroprotective component (kynurenic acid,a 
NMDA glutamate antagonist) in which  the neurode-
generative pathway predominates. Th us recent clinical 
and experimental evidence suggests that a dysfunc-
tional immune system contributes to both the acute 
symptoms and to long-term pathological changes in 
the brains of  those suff ering  from schizophrenia.
